| Year |
Citation |
Score |
| 2023 |
Li W, Nakano H, Fan W, Li Y, Sil P, Nakano K, Zhao F, Karmaus PW, Grimm SA, Shi M, Xu X, Mizuta R, Kitamura D, Wan Y, Fessler MB, et al. DNASE1L3 enhances antitumor immunity and suppresses tumor progression in colon cancer. Jci Insight. PMID 37581941 DOI: 10.1172/jci.insight.168161 |
0.336 |
|
| 2019 |
Chen P, Wang S, Janardhan KS, Zemans RL, Deng W, Karmaus P, Shen S, Sunday M, Que LG, Fessler MB, Zhong XP. Efficient CD4Cre-Mediated Conditional KRas Expression in Alveolar Macrophages and Alveolar Epithelial Cells Causes Fatal Hyperproliferative Pneumonitis. Journal of Immunology (Baltimore, Md. : 1950). PMID 31315887 DOI: 10.4049/Jimmunol.1900566 |
0.425 |
|
| 2015 |
Kaplan BL, Li J, LaPres JJ, Pruett SB, Karmaus PW. Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology. Toxicological Sciences : An Official Journal of the Society of Toxicology. 145: 214-32. PMID 26008184 DOI: 10.1093/Toxsci/Kfv060 |
0.652 |
|
| 2015 |
Liu C, Chapman NM, Karmaus PW, Zeng H, Chi H. mTOR and metabolic regulation of conventional and regulatory T cells. Journal of Leukocyte Biology. PMID 25714803 DOI: 10.1189/Jlb.2Ri0814-408R |
0.329 |
|
| 2014 |
Shrestha S, Yang K, Wei J, Karmaus PW, Neale G, Chi H. Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs. Proceedings of the National Academy of Sciences of the United States of America. 111: 14858-63. PMID 25271321 DOI: 10.1073/pnas.1404264111 |
0.368 |
|
| 2014 |
Karmaus PW, Chi H. Genetic dissection of dendritic cell homeostasis and function: lessons from cell type-specific gene ablation. Cellular and Molecular Life Sciences : Cmls. 71: 1893-906. PMID 24366237 DOI: 10.1007/s00018-013-1534-7 |
0.323 |
|
| 2013 |
Yang K, Shrestha S, Zeng H, Karmaus PW, Neale G, Vogel P, Guertin DA, Lamb RF, Chi H. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. Immunity. 39: 1043-56. PMID 24315998 DOI: 10.1016/j.immuni.2013.09.015 |
0.321 |
|
| 2013 |
Karmaus PW, Wagner JG, Harkema JR, Kaminski NE, Kaplan BL. Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice. Journal of Immunotoxicology. 10: 321-8. PMID 23173851 DOI: 10.3109/1547691X.2012.741628 |
0.699 |
|
| 2013 |
Karmaus PW, Chen W, Crawford R, Kaplan BL, Kaminski NE. Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. Toxicological Sciences : An Official Journal of the Society of Toxicology. 131: 419-33. PMID 23152191 DOI: 10.1093/Toxsci/Kfs315 |
0.772 |
|
| 2012 |
Karmaus PW, Chen W, Kaplan BL, Kaminski NE. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 843-55. PMID 21789506 DOI: 10.1007/S11481-011-9293-4 |
0.718 |
|
| 2011 |
Karmaus PW, Chen W, Crawford RB, Harkema JR, Kaplan BL, Kaminski NE. Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection. Journal of Leukocyte Biology. 90: 983-95. PMID 21873455 DOI: 10.1189/Jlb.0511219 |
0.793 |
|
| 2010 |
Kaplan BL, Lawver JE, Karmaus PW, Ngaotepprutaram T, Birmingham NP, Harkema JR, Kaminski NE. The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicologic Pathology. 38: 382-92. PMID 20190202 DOI: 10.1177/0192623310362706 |
0.652 |
|
| 2008 |
Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 84: 1574-84. PMID 18791168 DOI: 10.1189/jlb.0508282 |
0.773 |
|
| 2008 |
Buchweitz JP, Karmaus PW, Williams KJ, Harkema JR, Kaminski NE. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 83: 785-96. PMID 18073275 DOI: 10.1189/Jlb.0907618 |
0.788 |
|
| 2007 |
Buchweitz JP, Karmaus PW, Harkema JR, Williams KJ, Kaminski NE. Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice. The Journal of Pharmacology and Experimental Therapeutics. 323: 675-83. PMID 17726158 DOI: 10.1124/Jpet.107.124719 |
0.769 |
|
| Show low-probability matches. |